共 45 条
- [1] Coleman R.E., Management of bone metastases, Oncologist, 5, pp. 463-470, (2000)
- [2] Melton III L.J., Kyle R.A., Achenbach S.J., Oberg A.L., Rajkumar S.V., Fracture risk with multiple myeloma: A population-based study, Journal of Bone and Mineral Research, 20, 3, pp. 487-493, (2005)
- [3] Coleman R.E., Clinical features of metastatic bone disease and risk of skeletal morbidity, Clinical Cancer Research, 12, (2006)
- [4] Lecouvet F.E., Vande B. C B., Maldague B.E., Michaux L., Laterre E., Michaux J.L., Ferrant A., Malghem J., Vertebral compression fractures in multiple myeloma. Part I. Distribution and appearance at MR imaging, Radiology, 204, pp. 195-199, (1997)
- [5] Klimo P., Schmidt M.H., Surgical management of spinal metastases, Oncologist, 9, pp. 188-196, (2004)
- [6] Costa L., Badia X., Chow E., Lipton A., Wardley A., Impact of skeletal complications on patients' quality of life, mobility, and functional independence, Support Care Cancer, 16, pp. 879-889, (2008)
- [7] Silverman S.L., The clinical consequences of vertebral compression fracture, Bone, 13, (1992)
- [8] Lindsay R., Silverman S.L., Cooper C., Risk of new vertebral fracture in the year following a fracture, JAMA, 285, pp. 320-323, (2001)
- [9] Francis R.M., Baillie S.P., Chuck A.J., Crook P.R., Dunn N., Fordham J.N., Kelly C., Rodgers A., Acute and long-term management of patients with vertebral fractures, Q J Med, 97, pp. 63-74, (2004)
- [10] Von Moos R., Strasser F., Gillessen S., Zaugg K., Metastatic bone pain. treatment options with an emphasis on bisphosphonates, Support Care Cancer, 16, pp. 1105-1115, (2008)